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Background: Diabetic foot complications are a leading cause of lower extremity amputation. 
With the increasing incidence of diabetes mellitus in the Arab world, specifically in the 
Kingdom of Saudi Arabia, the rate of amputation will rise significantly. A diabetic foot care 
program was implemented at King Abdulaziz Medical City in Riyadh, Saudi Arabia, in 2002. 
The program was directed at health care staff and patients to increase their awareness about 
diabetic foot care and prevention of complications. The purpose of this study was to perform 
a primary evaluation of the program’s impact on the rate of lower extremity amputation due to 
diabetic foot complications.
Method: This pilot study was the first analysis of the diabetic foot care program and examined 
two groups of participants for comparison, ie, a “before” group having had diabetic foot ulcers 
managed between 1983, when the hospital was first established, and 2002 when the program 
began and an “after group” having had foot ulcers managed between 2002 and 2004, in the 
program’s initial phase. A total of 41 charts were randomly chosen retrospectively. A data sheet 
containing age, gender, medical data, and the presentation, management, and outcome of diabetic 
foot cases was used for the analysis.
Results: The before group contained 20 patients (17 males) and the after group contained 21 
patients (16 males). There was no difference between the two groups with regard to age and 
comorbidities. The rate of amputation was 70% in the before group and 61.9% in the after group. 
There was a decrease in the percentage of toe amputation in the after group and an increase in 
the percentage of below-knee amputation in the before group. However, these changes were 
not significant.
Conclusion: The program, although evaluated at an early stage, has increased the awareness 
of both patients and health care staff about the prevention and management of diabetic foot 
disease, and decreased the rate of lower extremity amputation. We believe that the statistical 
proof of its impact will be evident in the final evaluation.
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Introduction
Foot complications from diabetes are one of the main causes of amputation and its 
subsequent physical and emotional problems. Peripheral vessels and nerve disorders 
may lead to foot ulcers, and superadded infection can cause foot gangrene. This prob-
lem is one of the main reasons for admission of diabetic patients to hospital, and leads 
to billions of dollars in medical expenses worldwide.1,2 In Saudi Arabia and the Arab 
world, the incidence is even higher.3–5 Diabetes-related lower extremity conditions that 
increase the risk for amputation among people with diabetes include peripheral neu-
ropathy, peripheral vascular disease, and infection.6 Peripheral neuropathy may cause Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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loss of sensation in the feet, resulting in a patient’s failure 
to perceive foot problems, and may cause development of 
foot deformities that increase pressure points susceptible to 
ulceration. Osteomyelitis and gangrene may develop from 
inadequate blood supply and infection. Risk factors for 
amputation include being older, male, or a member of certain 
racial/ethnic groups, having poor glycemic control, having 
diabetes for a longer period, and practicing or receiving poor 
preventive health care.7
Lower extremity amputation, a devastating consequence 
of diabetes, remains a very common outcome of diabetic foot 
complications.8,9 Indeed, people with diabetes are 10–15 times 
more likely to require lower extremity amputation than non-
diabetic individuals, with a 30%–50% higher risk of undergo-
ing a second amputation. Furthermore, the mortality rate for 
patients undergoing amputation is 6%. Amputation is not only 
a costly outcome for patients, but also expensive for the health 
care system. In one estimate, managing one patient with an 
amputation will cost around $40,000 to $75,000.10–12
A recent national study on the prevalence of diabetes in 
Saudi Arabia revealed that 25% of Saudis over 40 years of 
age have diabetes.13 Given these statistics, the economic and 
social implications are apparent and significant.
The diabetic foot care program implemented at King 
Abdulaziz Medical City in Riyadh in 2002 is a comprehensive 
approach to maintaining the health of diabetic patients’ feet 
in order to reduce the lower limb amputation rate, thereby 
dramatically reducing the cost to patients, society, and the 
health care system. Knowledgeable and consistent care can 
help patients avoid the potential problems that may lead to 
amputation. The patients’ continued walking ability and 
quality of life depend on close inspection, proper footwear, 
a few specific “do’s and don’ts”, and the commitment of the 
medical care team.14
The purpose of this retrospective study was to evaluate the 
initial impact of the program on the rate of lower extremity 
amputation due to diabetic foot complications.
Methods
In 2002, a diabetic foot care team was formed to revise and 
establish a proposed diabetic foot care program. The members 
were specialists involved in diabetic foot management and 
professionals who had an interest in the program. The team 
consisted of a vascular surgeon, a diabetologist, an infectious 
disease internist, a diabetic educator, surgical and medical 
nurses, and a general surgeon. The aim of the program was to 
determine the impact of a diabetic foot education program on 
the prevention and outcomes of diabetic foot complications 
in our main hospital and satellite primary care clinics. The 
objectives were to increase the knowledge of patients and 
health care staff about diabetic foot care, to increase the skills 
of patients and staff regarding methods for diabetic foot care 
in order to prevent and manage diabetic foot lesions, and to 
encourage health care staff to undertake regular foot exami-
nation and foot care education in their practice.
The program included foot care education for health care 
staff, which included the following elements: how to stratify 
and manage patients in low- and high-risk categories, for 
which a screening data sheet was provided (Appendix 1); 
how to apply standard wound care practice protocols; and 
how to follow the guidelines set out in the institution’s refer-
ral system for patients with either low- or high-risk diabetic 
foot problems, including early referral of high-risk patients 
to a specialist. The education methods for health care staff 
consisted of lectures on diabetic foot care given at regular 
intervals and in regular diabetic foot workshops. These work-
shops were one-day activities conducted by the diabetic foot 
team. All health care providers in our hospital and satellite 
clinics caring for diabetes patients were permitted to attend. 
The morning program consisted of didactic lectures with 
photographic illustrations, as well as interactive discussions. 
In the afternoon program, the participants divided into groups 
and rotated among stations. The first station involved hands-on 
practice on how to assess foot vascularity and was taught by a 
vascular surgeon. In the second station, a physician instructed 
participants on how to assess for the presence of neuropathy. 
The third station was taught by a diabetic foot educator who 
gave participants general knowledge about the importance of 
footwear, examples of major amputation caused by improper 
footwear, and various examples of foot deformities and minor 
amputations. By the end of 2004, four workshops had been 
conducted, with a total of 98 participants. Patient education 
was mainly provided by a diabetic educator, who conducted 
educational series and distributed educational pamphlets.
The diabetic foot team monitored the program through 
feedback from health care staff and patients. Questionnaires 
were conducted at the end of every activity (workshops and 
lectures) and short questionnaires were given at random 
time points to evaluate patient and staff knowledge about 
the program. These were used to evaluate the program and 
determine how it could be improved. Program information 
and results were entered in the hospital’s data system.
Our aim is to re-evaluate the program’s impact at the end 
of 2012, ie, 10 years after its inception. However, in this 
primary evaluation, the program’s initial results (from 2002 
to the end of 2004) were analyzed.Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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The sample size for this study was 41 patients at King 
Abdulaziz Medical City in Riyadh. The hospital uses the 
International Classification of Diseases, Eighth Revision, Clinical 
Modification (ICD-8-CM). The ICD-8-CM system provides 
codes to classify a wide variety of signs, symptoms, abnormal 
findings, complaints, social circumstances, and external causes of 
injury or disease. After approval from the research committee at 
the hospital and the university, we chose diabetic foot ulcers and 
cellulitis as codes with which to collect the sample populations.
For this first analysis, a total of 41 charts were randomly 
chosen and retrospectively reviewed. Twenty belonged 
to patients who presented with diabetic foot complica-
tions between 1983 and 2002 (the “before group”), and 
21 to patients who presented with such complications 
in the program’s first two years, from 2002 to 2004 
(the “after” group). Patients were evaluated by searching 
each patient’s hospital record for previous admissions and 
outpatient visits related to diabetic foot complications. 
A data sheet (Appendix 2) designed to include multiple 
parameters related to diabetic foot management, was completed 
by a medical student, and supervised and revised by the author. 
Demographic data included gender, age, type, complications, 
duration of diabetes, comorbidities, presentation, investigations, 
and operative data. Only data pertaining to the objectives of 
our study were analyzed. The outcome of each group’s diabetic 
foot ulcers, ie, either healing or amputation, was compared. 
The data were analyzed using the SPSS program (SPSS Inc., 
Chicago, IL). Chi-square tests were used to compare categoric 
data and t-tests were used for both categoric and continuous 
measures. Statistical significance was declared for one-tailed 
P values of 0.05.
Results
For the purpose of this evaluation, data pertaining to the 
objectives of our study were analyzed. Theses were demo-
graphic data, diabetes duration, risk factors for development 
of diabetic foot complications, clinical presentation, and the 
outcome of the diabetic foot complication. Males comprised 
76.2% of the after group and 85% of the before group. The mean 
age was 61.1 years for the after group and 58.6 years for the 
before group. The mean duration of diabetes in both groups 
was not significant. In the after group, the mean duration was 
16.83 years, with a standard deviation of 8.34 years, with nine 
patients missing documentation of diabetes duration. In the 
before group, the mean duration was 13.29 years with a stan-
dard deviation of 10 years, with four undocumented patients 
(Table 1). There were no neuropathies in the before group, 
while 23.8% of the after group had neuropathies. There were 
Table 1 Patient demographic data, comorbidities, and complications
Characteristics After 
(2002 to 2004)
Before 
(1983–2002)
P value
n 21 20 n/A*
Men  16 17 0.69
Age (years) 61.1 ± 13.7 58.6 ± 10.18 0.49
Type 2/Type 1 
diabetes
17/3 15/1 0.61
neuropathy (%) 23.8 0 0.027
Peripheral arterial 
disease (%)
4.8 0 0.512
Abbreviation: n/A, not applicable.
also no vascular problems in the before group, while 4.8% 
of the after group had vascular problems. All patients in the 
after group presented with an ulcer, compared with 85% 
of the before group. Patients in the after group also had a 
higher chance of presenting with gangrene and osteomyelitis 
(63.3% and 42.9%, respectively), (Table 2). The overall 
amputation rate was higher in the before group at 70% than 
in the after group (70% versus 61.9%, respectively). Toe 
amputation was lower in the after group at 28.6%, while 
below-knee amputation was higher in the before group at 
33.3% (Table 3).
Discussion
The study shows that there was an 8.1% reduction in 
amputation rate after implementation of the program, but this 
was not statistically significant. The percentage of the cases 
that required amputation at the level of the toes was actually 
lower in the before group, while the percentage of patients 
who required amputation at below-knee level was higher in 
the after group. In addition, one case required above-knee 
amputation, which represents 5% of the before group. We 
observed that there were no neuropathies in the before group, 
while 23.8% of the after group had neuropathies. There were 
also no vascular problems in the before group, while 4.8% 
of the after group had vascular problems.
The literature is replete with studies demonstrating the 
major impact of increasing patients’ and health care providers’ 
awareness about foot care and changing their behaviors and 
practices regarding the prevention of ulcers and amputa-
tion. For instance, Lavery et al found that implementing a 
lower extremity disease management program consisting 
of screening and treatment protocols for diabetic members 
in a managed care organization decreased the incidence of 
amputations by 47.4%.15–19 Studies from several countries 
have shown that increasing awareness of diabetic foot care, 
as well as its prevention and proper management, resulted Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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in a 50% reduction in major amputation rates.20–22 However, 
those studies are reported from developed countries. Few to 
none of the developing countries have implemented such a 
program, although they have a higher incidence of diabetes 
and diabetic foot complications. To our knowledge, our 
program is the first attempt to implement such a program in 
our part of the world.
We believe that the following factors might have affected 
our results. The differences in neuropathy, vasculopathy, and 
other risk factors for diabetic foot complications were mainly 
due to highly deficient chart documentation in the before 
group, which demonstrates the low awareness of the diabetic 
foot problem in general. Despite this, the encouraging finding 
was that all patients in the after group presented with a foot 
ulcer. This could be due to the increased awareness of the 
general practitioners or other front-line physicians who par-
ticipated in the program and became more aware of the impor-
tance of referring patients with early ulcers to a specialist. In 
addition, patients educated in the program learned to seek 
immediate medical advice when they found any lesions on 
their feet. This could explain the lower percentage of toe 
amputation in the after group, which may have decreased due 
to early management of foot ulcers. On the other hand, the 
after group had a higher percentage of below-knee amputation. 
This could be explained by the random selection of charts or 
by the presentation of patients from other cities or hospitals 
with no foot care program (because our hospital is a tertiary 
centre, difficult or poorly managed cases are often referred). 
Our initial results did not replicate other international experi-
ence, which has established the effectiveness of establishing 
a diabetic foot care program in reducing the amputation rate. 
Nevertheless, this was also the experience of some other 
programs in their initial stages.23,24
Given that this was a pilot study, limitations include a 
small sample size, a short duration of follow-up, and missing 
data in the charts of both groups. In addition, the after group 
was chosen too early, so the protocols of the program had not 
yet been well implemented or disseminated to all health care 
providers. The poor compliance of patients with follow-up 
and prevention education is also an important factor. Other 
factors that are unique to our part of the world no doubt 
represent an important contribution to the delay in obtaining 
the required results of the program. These include education 
(because there is a high percentage of illiterate people in the 
community), the media (which pays less attention to medi-
cal problems here than in other countries), and the common 
belief that traditional management (herbal medicine, cautery, 
bloodletting) is more effective than modern medicine.3,5 The 
latter is, in the author’s view, the main determining factor.
Based on the results we have seen since 2004, we believe 
that our program will have a significant impact on reducing 
the rate of amputation due to diabetic foot complications, and 
this will be demonstrated in our next evaluation. Patients, 
health care staff, and even hospital admission censuses are 
showing a decrease in the rate of advanced diabetic foot 
complications. Operating room statistics are also showing a 
decline in amputation procedures. Moreover, general practi-
tioners and endocrinologists are reporting changes in patients’ 
behavior regarding foot care, and patients frequently ask that 
their feet be checked at all visits. The pattern of referral to 
our vascular clinic has changed from advanced diabetic foot 
lesions to early ulcers.
Educating health care staff and patients about diabetic foot 
complications and increasing their awareness will no doubt 
have a significant impact on reducing the rate of amputation; 
however, it will require commitment and patience to achieve the 
required results, especially in communities where education is 
still growing, as in developing countries. Achieving these results 
will encourage hospital administrators and policy makers to 
support and disseminate the program to other institutions.
Developing countries differ in their amount of resources 
and level of government support. Our program does not 
require financial support or advanced resources, so we rec-
ommend its use in all developing countries with diabetic foot 
crises, because it is easily conducted without financial burden. 
Table 3 Amputation level
Amputation 
level
After 
(2002 to 2004)
Before 
(1983 to 2002)
P value
n  21 20
Overall 
amputation (%)
61.9 70 0.314
Toe level (%) 28.6 40 n/s
Below-knee 
level (%)
33.3 20 n/s
Above-knee 
level (%)
0 0.5 n/s
Abbreviation: N/S, not significant.
Table 2 Presentations and investigations
Presentation After 
(2002–2004)
Before 
(1983–2002)
P value
n  21 20
Ulcers (%) 100 85 0.329
gangrene (%) 63.3 36.4 0.272
Osteomyelitis 
of foot X-ray (%)
42.9 38.9 n/A
Abbreviation: n/A, not available.Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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It only requires a caring enthusiastic group of health care staff 
who can adapt the program and tailor it to their capabilities 
in order for good long-term results to be achieved.
Conclusion
Although our initial results did not replicate those of other 
international studies which have shown the effectiveness of 
diabetic foot care programs in reducing the amputation rate, 
we have found that this was the experience of some other 
programs in their initial stages. Therefore, we believe that 
the second stage of evaluation will demonstrate a significant 
improvement in the lower limb amputation rate of diabetic 
patients in our hospital.
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(Continued)
Diabetic foot evaluation form: Date :   ---------
History
Diabetes mellitus Type I    Type II on insulin   Oral agents    None 
Other diagnoses: _____________________________________________ 
HX foot ulcer    Y      N                 Surgery Y   N 
Employed   Y     N 
Activity:    sitting ___ %       versus standing/walking ___ % 
Independent ambulation  Ambulatory aids 
Ambulation distance   Unlimited    Limited 
Homebound   Nonambulatory 
Exercise Y   N 
Other  __________________________________________________ 
________________________________________________________
Sensation/Skin
Monofilament test 
B A
          Apply sufficient force to cause the filament to bend 
AppendicesVascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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LEFT RIGHT
Label:  positive (can feel monofilament) 
             negative (cannot = loss of protective sensation) 
D = dryness, S = swelling, R = redness, T = temperature
M = maceration,   C = callus   P = preulcer    U = ulcer
Vascular
Right
Y N Dorsal pedal pulse N
YN Posterior tibial pulse N
YN Shiny, hairless, atrophic skin N
YN Capillary refill < 3 sec N
Y
Y
Y
Y
Other __________________________________
__________________________________________________
Deformities
Right                                                        Left 
Footwear
Standard     Y     N             Prescription Y   N 
 N  Appropriate  Y      N  Worn         Y 
Left
(Continued)Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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Appendix 1 King Abdulaziz Medical city Diabetic Foot Program screening sheet.
Assessment 
Foot injury risk  
  0 - No loss of  protective sensation 
  1 - Loss of protective sensation 
  2 - Loss of protective sensation and  high pressure 
(callus or deformity) and/or poor circulation 
  3 - History or foot ulcer or Charcot fracture 
Other _________________________________________ 
_______________________________________________________________________________
_________________
Plan
                      ______________________________________ 
Signature Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
931
Diabetic foot care education program
No:
Admission No: 
===============================================================
MR:----------------- Age:--------- Gender:----------  Saudi       Non-Saudi
DOA:---------------------------- DOD:--------------------------- 
ADMISSION  :  Elective     Urgent Emergency  Transfer
ADMITTING SERVICE:
MEDICAL DATA: 
Smoking           Duration:-----------
Diabetes mellitus:       Type I         Type II         Duration :----------------- 
Complications:  Retinopathy         Nephropathy   Neuropathy         Polyneuropathy
Mononeuropathy
Diet  OHD  OHD + INS   Beta-blockers    Other medications:------------------------------------
-------
Hypertension  Congestive heart failure  Ischemic heart disease    Lipids      TYPE:--------------
-------------------------------------
 FHX  Ischemic heart disease  Peripheral vacular disease  Cerebrovascular accident 
Vasculitis  Renal failure  on dialysis   Chronic obstructive pulmonary disease
________
SYMPTOMS:
Claudication  Duration:---------------------       Distance:------------------------------
Rest pain    Gangrene
Previous admissions    Previous surgery    Date of initial treatment:--------------
EXAMINATION SITES:
Infection    Abscess      Cellulitis   Necrosis        Ulcer
Ischemic Changes       Peripheral neuropathy 
Others
(Continued)Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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PULSES:
       RightL eft
PulseB ruit Doppler Pulse Bruit Doppler
Femoral
Popliteal
Dorsalis
pedis
Posterior
tibial
             A =  absent,   N = normal, W = weak
Exposed bone 
CAUSES:
Trauma     Burn      Trophic      Neuropathic
INVESTIGATIONS:
CBC:   White blood cells         Hb       Platlets           Urea         Creatinine          Cholesterol
Hemoglobin A1c: 
CARDIAC ASSESMENT: 
CAROTID EVALUATION 
ABI:       Right               Left 
TOE PRESSURE:         Right               Left
X-RAY FOOT: 
ANGIOGRAM:
 Preoperative      Intraoperative      Postoperative 
 Angioplasty__________               Stent 
Inflow:_________________________________________________________
Runoff:      Single vessel _________________
  2–3 vessels_________________ 
 X-rays _________________________   Bone scan_______________________
TYPE OF ORGANISM:      Swab culture and sensitivity       Tissue culture 
(Continued)Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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TREATMENT:
Antibiotics:       Initial                                                                Duration 
                         Post culture and sensitivity                              Duration 
DEBRIDEMENTS:
DRESSING:
OPERATIVE DATA:
 General anesthetic     Epidural     Regional     Local anesthetic
Revascularization      Bypass      Endarterectomy
Graft:      In situ    Reversed     Dacron     PTFE     Composite     Seqential 
Patch:    Vein    Dacron         PTFE
Inflow:  Site_________      Side to side     End to side     End to end 
Outflow: Site_________    Side to side     End to side     End to end 
∗Findings compared with angiogram:     Same      Different 
AMPUTATION:
OTHERS________________    Debridement     Flap     Skin graft 
Postoperative:     Warfarin     Aspirin     Intravenous heparin 
Second procedure:__________________________________________ 
HOSPITAL STAY: 
Complications and comments: 
_______________________________________________________________________________
_______________________________________________________________________________
_______________________________________________________________________________
_______________________________________________________________________________
_______________________________________________________________________________
_______________________________________________________________________________
_________
Toe:     Metatarsal     Below-knee    Above-knee
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Appendix 2 King Abdulaziz Medical city, Diabetic Foot care Program data sheet.
MORTALITY: < 30 days  > 30 days   Date of death__/__/__ 
Cause of death:  __________________________________________________ 
Other causes:____________________________________________________ 
Discussed in morbidity and mortality meeting     Yes     No 
    Filled in by:______________ 